StockData
QuidelOrtho Corp logo

QuidelOrtho Corp (QDEL) stock

QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3063% below fair value
$9.87−0.34 (-3.33%)

Close on Nov 17, 2026Market cap $676.84MP/E –Yield –

QuidelOrtho gross margin

Gross margin is gross profit as a percentage of revenue.

QuidelOrtho's gross margin for the twelve months ending Sep 27, 2026 was 44.2%. For fiscal 2025 it was 46.7%, against 46.2% the year before. The highest annual figure on record is 81.6% in fiscal 2020.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 28, 202546.7%+0.4
FY2024Dec 29, 202446.2%−3.7
FY2023Dec 31, 202349.9%−9.3
FY2022Jan 1, 202359.3%−16.0
FY2021Jan 2, 202275.3%−6.4
FY2020Jan 3, 202181.6%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 27, 202646.8%−1.2
Q2 FY2026Jun 28, 202643.3%−1.5
Q1 FY2026Mar 29, 202642.6%−7.0
Q4 FY2025Dec 28, 202544.3%−1.8
Q3 FY2025Sep 28, 202547.9%−0.5
Q2 FY2025Jun 29, 202544.8%+1.5
Q1 FY2025Mar 30, 202549.6%+2.8
Q4 FY2024Dec 29, 202446.1%−5.4
Q3 FY2024Sep 29, 202448.5%−1.2
Q2 FY2024Jun 30, 202443.3%−1.3
Q1 FY2024Mar 31, 202446.7%−6.3
Q4 FY2023Dec 31, 202351.5%−0.3
Q3 FY2023Oct 1, 202349.7%−2.3
Q2 FY2023Jul 2, 202344.6%−10.4
Q1 FY2023Apr 2, 202353.0%−21.0
Q4 FY2022Jan 1, 202351.8%−25.3
Q3 FY2022Oct 2, 202252.0%−21.6
Q2 FY2022Jul 3, 202255.0%−6.1
Q1 FY2022Apr 3, 202274.0%–
Q4 FY2021Jan 2, 202277.1%–
Q3 FY2021Oct 3, 202173.6%–
Q2 FY2021Jul 4, 202161.2%–

More QuidelOrtho figures

See a number that looks wrong?